Abstract
The type I human T-cell leukemia virus (HTLV-I) induces abnormal growth and subsequent transformation of T cells, which is associated with the development of an acute T-cell malignancy termed adult T-cell leukemia. A characteristic of HTLV-I-transformed T cells is the constitutive nuclear expression of NF-κB/Rel family of transcription factors, which appears to be essential for the growth of these transformed cells. Although NF-κB/Rel factors are known to induce the expression of T-cell growth factor interleukin (IL)-2, it is unclear how they participate in the IL-2-independent growth of HTLV-I-transformed cells. In this study, we show that certain NF-κB/Rel members, predominantly c-Rel, interact with enhancer sequences for STAT5, a key transcription factor mediating IL-2-induced T-cell proliferation. Reporter gene assays reveal that the binding of c-Rel to the STAT5 site present in the FcγR1 gene leads to potent transactivation of this enhancer. Binding of c-Rel to the FcγR1 STAT site also occurs in human peripheral blood T cells immortalized with HTLV-I in vitro and is correlated with enhanced levels of proliferation of these cells. These results raise the possibility that NF-κB/Rel may participate in the growth control of HTLV-I-transformed T cells by regulating genes driven by both κB and certain STAT enhancers.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Akagi T, Ono H, Nyunoya H and Shimotohno K. . 1997 Oncogene 14: 2071–2078.
Becker S, Groner B and Müller CW. . 1998 Nature 394: 145–151.
Beg AA and Baldwin Jr, AS. . 1993 Genes Dev. 7: 2064–2070.
Brockman JA, Scherer DC, McKinsey TA, Hall SM, Qi X, Lee WY and Ballard DA. . 1995 Mol. Cell. Biol. 15: 2809–2818.
Darnell Jr JE, Kerr IM and Stark GR. . 1994 Science 264: 1415–1421.
Doerre S, Sista P, Sun S-C, Ballard DW and Greene WC. . 1993 Proc. Natl. Acad. Sci. USA 90: 1023–1027.
Feuer G and Chen ISY. . 1992 Biochim. Biophys. Acta 1114: 223–233.
Fujii H, Nakagawa Y, Schindler U, Kawahara A, Mori H, Bouilleux F, Groner B, Ihle JN, Minami Y, Miyazaki T and Taniguchi T. . 1995 Proc. Natl. Acad. Sci. USA 92: 5482–5486.
Ganchi PA, Sun S-C, Greene WC and Ballard DW. . 1992 Mol. Biol. Cell 3: 1339–1352.
Gazdar AF, Carney DN, Bunn PA, Russell EK and Jaffe GP. . 1980 Blood 55: 409–417.
Gilmore TD. . 1990 Cell 62: 841–843.
Good L and Sun S-C. . 1996 J. Virol. 70: 2730–2735.
Holbrook N, Gulino A and Ruscetti F. . 1987 Virology 157: 211–219.
Höllsberg P, Wucherpfennig KW, Ausubel AJ, Calvo V, Bierer BE and Hafler DA. . 1992 J. Immunol. 148: 3256–3263.
Ihle JN. . 1996 Cell 84: 331–334.
Johnston JA, Bacon CM, Finbloom DS, Rees RC, Kaplan D, Shibuya K, Ortaldo JR, Gupta S, Chen YQ, Giri JD and O'Shea JJ. . 1995 Proc. Natl. Acad. Sci. USA 92: 8705–8709.
Johnston JA, Kawamura M, Kirken RA, Chen YQ, Blake TB, Shibuya K, Ortaldo JR, McVicar DW and O'Shea JJ. . 1994 Nature 370: 151–153.
Kanno T, Brown K, Franzoso G and Siebenlist U. . 1994 Mol. Cell. Biol. 14: 6443–6451.
Kitajima I, Shinohara T, Bilakovics J, Brown DA, Xu X and Nerenberg M. . 1992 Science 258: 1792–1795.
Koeffler HP, Chen IS and Golde DW. . 1984 Blood 64: 482–490.
Köntgen F, Grumont RJ, Strasser A, Metcalf D, Li R, Tarlinton D and Gerondakis S. . 1995 Genes & Dev. 9: 1965–1977.
Lacoste J, Petropoulos L, Pépin N and Hiscott J. . 1995 J. Virol. 69: 564–569.
Li C-C, Ruscetti FW, Rice NR, Chen E, Yang N-S, Mikovits J and Longo DL. . 1993 J. Virol. 67: 4205–4213.
Lin J-X, Migone T-S, Tsang M, Friedmann M, Weatherbee JA, Zhou L, Yamauchi A, Bloom ET, Mietz J, John S and Leonard WJ. . 1995 Immunity 2: 331–339.
McKinsey TA, Brockman JA, Scherer DC, Al-Murrani SW, Green PL and Ballard WB. . 1996 Mol. Cell. Biol. 16: 2083–2090.
Merl S, Kloster B, Moore J, Hubbell C, Tomar R, Davey F, Kalinowski D, Planas A, Ehrlich G and Clark D. . 1984 Blood 64: 967–974.
Migone T-S, Lin J-X, Cereseto A, Mulloy JC, O'Shea JJ, Franchini G and Leonard WJ. . 1995 Science 269: 79–81.
Miyoshi I, Kubonishi I, Yoshimoto S and Shiraishi Y. . 1981 Gann 72: 978–981.
Mui AL-F, Wakao H, O'Farrell A-M, Harada N and Miyajima A. . 1995 EMBO J. 6: 1166–1175.
Mulloy JC, Migone T-S, Ross TM, Ton N, Green PL, Leonard WJ and Franchini G. . 1998 J. Virol. 72: 4408–4412.
Nakajima K, Yamanaka Y, Nakae K, Kojima H, Ichiba M, Kiuchi N, Kitaoka T, Fukada T, Hibi M and Hirano T. . 1996 EMBO J. 15: 3651–3658.
O'Shea JJ. . 1997 Immunity 7: 1–11.
Persaud D, Munoz JL, Tarsis SL, Parks ES and Parks WP. . 1995 J. Virol. 69: 6297–6303.
Poiesz BF, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD and Gallo RC. . 1980 Proc. Natl. Acad. Sci. USA 77: 7415–7419.
Ressler S, Connor LM and Marriott SJ. . 1996 FEBS Microbiol. Lett. 140: 99–109.
Salahuddin SZ, Markham P, Wong-Staal F, Franchini G, Kalyanaraman VS and Gallo RC. . 1983 Virology 129: 51–64.
Schindler C and Darnell JE. . 1995 Annu. Rev. Biochem. 64: 621–651.
Schreiber E, Matthias P, Muller MM and Schaffner W. . 1989 Nucl. Acids Res. 17: 6419.
Schwartz RH. . 1990 Science 248: 1349–1356.
Shen C-H and Stavnezer J. . 1998 Mol. Cell. Biol. 18: 3395–3404.
Siebenlist U, Franzoso G and Brown K. . 1994 Annu. Rev. Cell Biol. 10: 405–455.
Smith MR and Greene WC. . 1991 J. Clin. Invest. 87: 761–766.
Sodroski J. . 1992 Biochim. Biophys. Acta 1114: 19–29.
Stancovski I and Baltimore D. . 1997 Cell 91: 299–302.
Sun S-C, Elwood J, Béraud C and Greene WC. . 1994 Mol. Cell. Biol. 14: 7377–7384.
Takemoto S, Mulloy JC, Cereseto A, Migone TS, Patel BK, Matsuoka M, Yamaguchi K, Takatsuki K, Kamihira S, White JD, Leonard WJ, Waldmann T and Franchini G. . 1997 Proc. Natl. Acad. Sci. USA 94: 13897–13902.
Uchiyama T. . 1997 Annu. Rev. Immunol. 15: 15–37.
Witthuhn BA, Silvennoinen O, Miura O, Lai KS, Cwik C, Liu ET and Ihle JN. . 1994 Nature 370: 153–157.
Xu X, Kang SH, Heidenreich O, Okerholm N, O'Shea JJ and Nerenberg MI. . 1995 J. Clin. Invest. 96: 1548–1555.
Yamaoka S, Inoue H, Sakurai M, Sugiyama T, Hazama M, Yamada T and Hatanaka M. . 1996 EMBO J. 15: 873–887.
Yoshida M. . 1995 J. Cancer Res. Clin. Oncol. 121: 521–528.
Yoshida M, Miyoshi I and Hinuma Y. . 1982 Proc. Natl. Acad. Sci. USA 79: 2031–2035.
Acknowledgements
We thank T Hirano for GRR-luc reporter, WC Greene for c-Rel cDNA expression vectors. EWH is supported by an NIH predoctoral training grant 5 T32 CA 6039-5. This study was Supported by Public Health Service grant 1 R01 CA68471-03 to SCS.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sun, SC., Maggirwar, S., Harhaj, E. et al. Binding of c-Rel to STAT5 target sequences in HTLV-I-transformed T cells. Oncogene 18, 1401–1409 (1999). https://doi.org/10.1038/sj.onc.1202430
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202430